Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2020
Headcount
—
HQ
null, Israel
Sector
Biotechnology
About
10FoldMed™ is an early-stage Israeli startup focused on treating obesity and metabolic-related diseases by reversing insulin resistance. They are developing a non-invasive device based on patent-pending Focused Ultrasound technology combined with machine learning capabilities to destroy visceral fat cells. The technology is currently in the development stage.
Q&A
- What is TenFoldMed's primary focus?
- TenFoldMed is an early-stage Israeli startup focused on treating obesity and metabolic-related diseases by reversing insulin resistance.
- What technology is TenFoldMed developing for its treatment?
- TenFoldMed is developing a non-invasive device based on patent-pending Focused Ultrasound technology combined with machine learning capabilities to destroy visceral fat cells.
- What stage of development is TenFoldMed's technology currently in?
- The technology being developed by TenFoldMed is currently in the development stage.
- When was TenFoldMed founded?
- TenFoldMed was founded in 2020.
- What is TenFoldMed's primary sector?
- TenFoldMed's primary sector is Biotechnology.
- Where is TenFoldMed headquartered?
- TenFoldMed is headquartered in Israel.
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | 10foldmed.com |
|---|
Identifiers & details
| Founded | 2020 |
|---|